XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.22.1

Other Long-Term Liabilities | 3 Months Ended
--- | ---
Mar. 31, 2022
Other Liabilities Disclosure [Abstract] |
Other Long-Term Liabilities | OTHER LONG-TERM LIABILITIES
(in millions) | March 31, 2022 |  |  | December 31, 2021
Contingent consideration | $ | 4.8 |  |  |  | $ | 5.4 |
Other | 0.1 |  |  |  | 0.2 |
Total other long-term liabilities | $ | 4.9 |  |  |  | $ | 5.6 |
The Company's balance of other long-term liabilities as of March 31, 2022 and December 31, 2021 consists primarily of the long-term portion of contingent consideration related to the acquisition of Sividon Diagnostics.

X
- References No definition available. + Details
Name: | us-gaap_OtherLiabilitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration